We are live on ! Find out more
SC

SummitTX Capital Portfolio holdings

AUM $3.2B
1-Year Est. Return 41.22%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+41.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.32B
AUM Growth
+$896M
Cap. Flow
+$807M
Cap. Flow %
24.32%
Top 10 Hldgs %
28.1%
Holding
1,021
New
296
Increased
249
Reduced
128
Closed
348

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$24.9M
2
FYBR
Frontier Communications
FYBR
+$17.5M
3
CAT icon
Caterpillar
CAT
+$15.2M
4
DTE icon
DTE Energy
DTE
+$15M
5
FTI icon
TechnipFMC
FTI
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 13.67%
2 Industrials 13.31%
3 Healthcare 11.55%
4 Consumer Discretionary 6.78%
5 Real Estate 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFGC icon
351
Performance Food Group
PFGC
$18B
$1.45M 0.04%
16,123
-2,073
-11% -$200K
SPOT icon
352
Spotify
SPOT
$103B
$1.45M 0.04%
2,490
+896
+56% +$560K
NVRI icon
353
Enviri
NVRI
$623M
$1.43M 0.04%
+80,030
New +$1.19M
ROIV icon
354
Roivant Sciences
ROIV
$24.5B
$1.43M 0.04%
65,887
-39,196
-37% -$773K
DORM icon
355
Dorman Products
DORM
$3.98B
$1.42M 0.04%
+11,506
New +$1.55M
VLTO icon
356
Veralto
VLTO
$23B
$1.41M 0.04%
+14,170
New +$1.43M
ZION icon
357
Zions Bancorporation
ZION
$10.2B
$1.4M 0.04%
23,939
+7,074
+42% +$385K
ALLY icon
358
Ally Financial
ALLY
$13.2B
$1.39M 0.04%
+30,596
New +$1.26M
VOYA icon
359
Voya Financial
VOYA
$9.01B
$1.39M 0.04%
18,601
+1,364
+8% +$99.4K
ALNY icon
360
Alnylam Pharmaceuticals
ALNY
$27.5B
$1.38M 0.04%
3,465
-4,060
-54% -$1.8M
STAA icon
361
PUT
STAAR Surgical
STAA
$1.21B
$1.36M 0.04%
+59,100
New +$1.52M
FNV icon
362
Franco-Nevada
FNV
$41.1B
$1.34M 0.04%
6,488
-32,703
-83% -$6.63M
BAC icon
363
Bank of America
BAC
$435B
$1.34M 0.04%
24,450
-24,594
-50% -$1.3M
CELC icon
364
Celcuity
CELC
$4.21B
$1.34M 0.04%
13,449
+3,612
+37% +$297K
PNC icon
365
PNC Financial Services
PNC
$99.7B
$1.34M 0.04%
+6,401
New +$1.24M
PNR icon
366
Pentair
PNR
$10.4B
$1.33M 0.04%
+12,756
New +$1.36M
EPRX
367
Eupraxia Pharmaceuticals
EPRX
$418M
$1.33M 0.04%
+175,948
New +$1.08M
NKTR icon
368
Nektar Therapeutics
NKTR
$2.39B
$1.33M 0.04%
31,353
+24,555
+361% +$1.37M
EBAY icon
369
eBay
EBAY
$50.6B
$1.32M 0.04%
15,202
+2,238
+17% +$194K
PAHC icon
370
Phibro Animal Health
PAHC
$1.47B
$1.32M 0.04%
+35,364
New +$1.44M
ALGS icon
371
Aligos Therapeutics
ALGS
$26.2M
$1.3M 0.04%
+139,424
New +$1.32M
TGTX icon
372
TG Therapeutics
TGTX
$7.96B
$1.28M 0.04%
43,092
+28,523
+196% +$932K
GOOG icon
373
Alphabet (Google) Class C
GOOG
$4.36T
$1.28M 0.04%
4,087
+1,471
+56% +$421K
BEPC icon
374
Brookfield Renewable
BEPC
$6.08B
$1.28M 0.04%
+33,335
New +$1.34M
ADBE icon
375
Adobe
ADBE
$99.5B
$1.27M 0.04%
3,629
-2,538
-41% -$863K

Similar funds

SummitTX Capital's Q4 2025 Portfolio in Review

As of Q4 2025, SummitTX Capital held 1,021 positions worth $3.32B, up 37% from $2.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

SummitTX Capital deployed $807M of net new capital in Q4 2025, opening 296 new positions and adding to 249 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 299,442 shares worth $57.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Teradyne, an estimated $24.9M trimmed.

  • SummitTX Capital's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 299,442 shares worth $57.4M.
  • SummitTX Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $185M increase.
  • SummitTX Capital's biggest Q4 2025 reduction was Teradyne, cutting an estimated $24.9M.
  • SummitTX Capital fully exited Caterpillar in Q4 2025, selling an estimated $15.2M.
  • SummitTX Capital's ten largest holdings make up 28% of its $3.32B portfolio in Q4 2025.
  • SummitTX Capital opened 296 new positions and closed 348 in Q4 2025.
  • SummitTX Capital's portfolio value rose 37% quarter-over-quarter to $3.32B.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.